Leizorovicz A - Search Results

1

Secondary prevention after high-risk acute myocardial infarction with low-dose acebutolol.

Boissel JP, Leizorovicz A, Picolet H, Peyrieux JC. Boissel JP, et al. Among authors: leizorovicz a. Am J Cardiol. 1990 Aug 1;66(3):251-60. doi: 10.1016/0002-9149(90)90831-k. Am J Cardiol. 1990. PMID: 2195860 Clinical Trial.

2

[Intermediary and substitution criteria in the development of anti-arrhythmia agents].

Lièvre M, Leizorovicz A, Boissel JP. Lièvre M, et al. Among authors: leizorovicz a. Arch Mal Coeur Vaiss. 1991 Feb;84 Spec No 2:27-33. Arch Mal Coeur Vaiss. 1991. PMID: 1669237 French.

3

Efficacy of acebutolol after acute myocardial infarction (the APSI trial). The APSI Investigators.

Boissel JP, Leizorovicz A, Picolet H, Ducruet T. Boissel JP, et al. Among authors: leizorovicz a. Am J Cardiol. 1990 Sep 25;66(9):24C-31C. doi: 10.1016/0002-9149(90)90759-t. Am J Cardiol. 1990. PMID: 2220646 Clinical Trial.

4

Pre-hospital and hospital time delays in thrombolytic treatment in patients with suspected acute myocardial infarction. Analysis of data from the EMIP study. European Myocardial Infarction Project.

Leizorovicz A, Haugh MC, Mercier C, Boissel JP. Leizorovicz A, et al. Eur Heart J. 1997 Feb;18(2):248-53. doi: 10.1093/oxfordjournals.eurheartj.a015227. Eur Heart J. 1997. PMID: 9043841 Clinical Trial.

5

Persistent reduction of mortality for five years after one year of acebutolol treatment initiated during acute myocardial infarction. The APSI Investigators. Acebutolol et Prévention Secondaire de l'Infarctus.

Cucherat M, Boissel JP, Leizorovicz A. Cucherat M, et al. Among authors: leizorovicz a. Am J Cardiol. 1997 Mar 1;79(5):587-9. doi: 10.1016/s0002-9149(96)00820-x. Am J Cardiol. 1997. PMID: 9068513 Clinical Trial.

6

Low molecular weight heparin in prevention of perioperative thrombosis.

Leizorovicz A, Haugh MC, Chapuis FR, Samama MM, Boissel JP. Leizorovicz A, et al. BMJ. 1992 Oct 17;305(6859):913-20. doi: 10.1136/bmj.305.6859.913. BMJ. 1992. PMID: 1281030 Free PMC article. Clinical Trial.

7

Coronary reperfusion rates in acute myocardial infarction patients after thrombolytic treatment with anistreplase: correlation with the delay from onset of symptoms to treatment: a review of 424 case records of patients admitted to coronary reperfusion studies with anistreplase.

Leizorovicz A, Boissel JP, Robert F. Leizorovicz A, et al. J Cardiovasc Pharmacol. 1992 Jan;19(1):34-9. doi: 10.1097/00005344-199201000-00005. J Cardiovasc Pharmacol. 1992. PMID: 1375685 Clinical Trial.

8

Relative efficacy of angiotensin converting enzyme inhibitors on mortality of patients with congestive heart failure: implications of randomized trials and role of the aetiology (ischaemic or non-ischaemic) of heart failure.

Nony P, Boissel JP, Girard P, Leizorovicz A, Lievre M, Chifflet R. Nony P, et al. Among authors: leizorovicz a. Eur Heart J. 1992 Aug;13(8):1101-8. doi: 10.1093/oxfordjournals.eurheartj.a060321. Eur Heart J. 1992. PMID: 1387085

9

Reliability of phlebography in the assessment of venous thrombosis in a clinical trial.

Picolet H, Leizorovicz A, Revel D, Chirossel P, Amiel M, Boissel JP. Picolet H, et al. Among authors: leizorovicz a. Haemostasis. 1990;20(6):362-7. doi: 10.1159/000216151. Haemostasis. 1990. PMID: 1965977 Clinical Trial.

10

Dose-effect relationship estimation for thrombolytic therapy in acute myocardial infarction.

Boissel JP, Leizorovicz A, Peyrieux JC. Boissel JP, et al. Among authors: leizorovicz a. Semin Thromb Hemost. 1987 Apr;13(2):181-5. doi: 10.1055/s-2007-1003491. Semin Thromb Hemost. 1987. PMID: 3114886 Clinical Trial. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

147 results

Search Page